H-1B Filings
12
Major sponsor. DOL labor condition applications on file.
Manufacturing MA DOL H-1B WARN Act
Sarepta Therapeutics, Inc.: WARN & Workforce Profile
Sarepta Therapeutics, Inc. in MA (Manufacturing) pairs H-1B sponsorship (12 LCAs) with WARN history (1 notice) and has no employer OSHA injury log here.
Sarepta Therapeutics, Inc. (MA): · 12 H-1B LCAs at a $148,000 disclosed median · 1 WARN notice
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Sarepta Therapeutics, Inc. in MA carries 12 H-1B wage filings on record, a $148,000 median wage across 11 disclosed-wage positions (above the $124,488 national median) and 1 WARN layoff notice on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
- 12 H-1B LCAs
- $148,000 median wage
- 1 WARN
Layoff & federal record
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #4,263 of 51,370 sponsors in this corpus (about the 91st percentile), and disclosed median wage sits at the 67th percentile of 272,125 credible H-1B wage rows.
- 91st pct
- H-1B filing rank
- 67th pct
- median wage rank
- 3%
- fewer WARN notices than
Figures above come from DOL H-1B LCAs and state WARN notices; no employer OSHA injury log is on file here.
D
Federal workforce composite
48/100
3 of 4 federal tracks · Sarepta Therapeutics, Inc.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Sponsorship scale A+
12 H-1B LCAs
#4,263 of 51,370 sponsors · 91st percentile by volume (DOL OFLC)
Disclosed pay B-
$148,000 median
67th percentile of 272,125 credible H-1B wage rows
Workplace safety N/A
No OSHA record
No employer-specific OSHA ITA injury log; weight redistributes (industry estimates never pad this dim).
Layoff stability F
1 WARN notice
Cleaner WARN history than 3% of 304,376 tracked employers (state workforce agencies)
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
DOL LCA release change
What changed between the two LCA fiscal years
- Sarepta Therapeutics, Inc.'s filing-count-weighted median disclosed H-1B wage rose from $123,752 in FY2024 to $144,166 in FY2025 (+16.5%).
Median H-1B Salary
$148,000
Above national median. Across 11 disclosed positions
WARN Workforce Impact
493 workers
Less stable than most peers. 1 WARN Act notice on file
Where Sarepta Therapeutics, Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$148,000 Top 33% higher than 67% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Sarepta Therapeutics, Inc.'s H-1B median wage, FY2024 vs FY2025
Filing-count-weighted median across this employer's own disclosed H-1B positions (+16.5% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
Government Data Summary
| Field | Value | Source |
|---|---|---|
| Employer Name | Sarepta Therapeutics, Inc. | DOL OFLC / WARN |
| Industry | Manufacturing | NAICS / DOL |
| State | MA | U.S. Federal Records |
| H-1B Filings | 12 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $148,000 | DOL OFLC LCA Disclosure |
| WARN Layoff Notices | 1 notice(s), 493 workers | WARN Act notices, state workforce agency originals (archival backstop: LayoffData.com) |
| Tracks not on file | employer OSHA injury log | Empty by design, not estimated |
Sarepta Therapeutics, Inc.'s values above reflect the most recent DOL Labor Condition Applications, WARN Act notices on file for this employer in MA (Manufacturing). In this corpus, H-1B filing volume ranks #4,263 of 51,370 sponsors in this corpus (about the 91st percentile); disclosed median wage sits at the 67th percentile of 272,125 credible H-1B wage rows; WARN notice count sits below 3% of 304,376 employers (more notices elsewhere).
H-1B Salary Data
| Job Title | Median |
|---|---|
| Executive Dir., Gene Therapy Commercialization Capabilities | $279,000 |
| Director, Regulatory Affairs CMC | $226,500 |
| Sr. Principal Engineer, Manufacturing Sciences & Technology | $196,000 |
| Principal Statistical Analyst | $149,000 |
| Principal Engineer, Manufacturing Sciences and Technology | $148,000 |
| Sr. Mgr, Capital Projects (Mechanical Engineer & HVAC) | $148,000 |
| Quality Control Investigations Manager | $140,000 |
| Project Manager, Scientific Business Development | $126,006 |
| Senior Engineer, Gene Therapy Upstream Process Development | $104,416 |
| Engineer, RNA Drug Substance Manufacturing | $85,000 |
| Research Associate, Gene Therapy | $72,000 |
What the Data Says About Sarepta Therapeutics, Inc.
Signature stat: WARN history
WARN history dominates: 1 notice put this employer among the 97% with the heaviest layoff filings in the corpus.
Heavy H-1B sponsor
Sarepta Therapeutics, Inc. in MA (Manufacturing) filed 12 H-1B labor condition applications, of which 11 disclose a usable wage figure at a $148,000 disclosed median — a top-tercile sponsorship footprint in this corpus.
Rising disclosed medians
Disclosed medians moved from $123,752 (FY2024) to $144,166 (FY2025) (+16.5%), weighted by this employer's own LCA rows — not a company-wide raise and not role-mix adjusted.
No OSHA record despite scale
Sarepta Therapeutics, Inc. sponsors 12 H-1B positions but carries no employer OSHA DART rate here — at this filing volume the gap usually reflects recordkeeping exemptions, not a verified safety judgment.
Top-quartile disclosed pay
Disclosed pay runs high: $148,000 median beats 67% of credible wage rows and sits above the $124,488 national median.
Growing LCA footprint
FY2025 added 1 filings versus FY2024 (25%), a sponsorship expansion visible in the raw LCA counts.
Dual-track profile
Sarepta Therapeutics, Inc. is one of the rarer profiles carrying both sponsorship volume (12 H-1B LCAs) and WARN history (1 notice) in the same public record (Manufacturing) in MA. Weigh those signals separately.
Where Sarepta Therapeutics, Inc. sits
This employer among Manufacturing H-1B peers
Across the 201 Manufacturing sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, Sarepta Therapeutics, Inc. files more petitions than 0% of them and discloses a higher median wage than 61%, the selective, above-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (12 filings · $148,000 median here).
Each muted dot is one manufacturing peer from a filings-stratified sample of 42; the brand marker is Sarepta Therapeutics, Inc.. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
How Sarepta Therapeutics, Inc. compares to Manufacturing peers
Sarepta Therapeutics, Inc.'s nearest H-1B-filing peers in Manufacturing (home state MA). Each card links to that employer's federal-records profile.
Sarepta Therapeutics, Inc.
12 H-1B filings
NVIDIA Corporation
1,989 H-1B filings
Intel Corporation
1,938 H-1B filings
WARN Act Layoff History
| Notice Date | Workers |
|---|---|
| 2025-07-17 | 493 |
What to check before working with Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. needs a three-way read: H-1B pay (12 LCAs), safety, and WARN history (1 notice); none of those alone is the rating.
- H-1B median is $148,000 across 11 disclosed-wage positions (of 12 total filings), benchmark any offer against it and the metro prevailing wage. Compare with peers
- 1 WARN layoff notice on file, review the timing before counting on job stability. Reading WARN notices
Sarepta Therapeutics, Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Read with this employer
- NVIDIA Corporation (CA) - 1,989 H-1B filings in the same Manufacturing roster
- Intel Corporation (CA) - 1,938 H-1B filings in the same Manufacturing roster
- Tesla, Inc. (TX) - 1,868 H-1B filings in the same Manufacturing roster
- Reading WARN notices - what Sarepta Therapeutics, Inc.'s layoff filings do and do not prove.
- H-1B salary negotiation - using disclosed wages like Sarepta Therapeutics, Inc.'s when you negotiate.
- Compare employers - put Sarepta Therapeutics, Inc. next to peers on pay, safety, and WARN.
- National H-1B & safety statistics - where Sarepta Therapeutics, Inc.'s #4,263 placement sits in the full federal roster.
Retrieved and formatted by PlainEmployers.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Frequently Asked Questions
Where does Sarepta Therapeutics, Inc.'s H-1B wage sit nationally?
Among 272,125 credible H-1B wage rows in this corpus, Sarepta Therapeutics, Inc.'s disclosed median of $148,000 sits at the 67th percentile (above the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
How does Sarepta Therapeutics, Inc.'s H-1B filing volume compare to other sponsors?
Sarepta Therapeutics, Inc. has 12 H-1B filings on record, ranking #4,263 of 51,370 sponsors in this corpus (about the 91st percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
Does Sarepta Therapeutics, Inc. have WARN layoff notices on file?
Yes - 1 WARN Act notice affecting about 493 workers appear in the state-agency corpus for this employer. WARN covers mass layoffs and plant closings that meet statutory thresholds; absence of notices is not a guarantee of stability.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and state WARN Act layoff notices, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.